Matthew Hershenhorn

Stock Analyst at Oppenheimer

(3.25)

# 2,394

Out of 4,442 analysts

Total ratings

100%

Success rate

89.5%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Matthew Hershenhorn

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	ACAD ACADIA Pharmaceuticals	Maintained: Hold	$23	$22.60	+1.77%	6	May 22, 2026
	AXSM Axsome Therapeutics	Rated: Buy	$183 → $250	$241.97	+3.32%	6	May 1, 2026

ACADIA Pharmaceuticals

May 22, 2026

Maintained: Hold

Price Target: $23

Current: $22.60

Upside: +1.77%

Axsome Therapeutics

May 1, 2026

Rated: Buy

Price Target: $183 → $250

Current: $241.97

Upside: +3.32%